Pre-order Enquiry
Request Free Sample
Healthcare
Aerospace & Defence
Agriculture
Automations
Chemicals & Advanced Materials
Food & Beverages
Information & Communication Technology
Oil & Gas
Power & Energy
The global Clinical Trial Supply Services market size was valued at USD 3550.62 Million in 2022 and will reach USD 5340.48 Million in 2028, with a CAGR of 7.04% during 2022-2028.
Clinical Trial Supply Services refers to the manufacturing, packaging, storage, distribution, project management, and inventory management for in clinical trial activities. Clinical Trial Supply Services include, but are not limited to, project management, clinical packaging, labeling, supply chain logistics, distribution, return drug accountability, and destruction.
The number of new groups in clinical trials dropped sharply at the beginning of the year because of COVID-19
Globally, COVID-19 is still raging. Many pharmaceutical companies suspend clinical trials due to the epidemic. Because of the recruitment of patients in most regions of the world was severely affected. In March, the number of enrolled groups in global clinical trials dropped by 65.1% year-on-year compared with 2019
European Medicines Agency (EMA), U.S. Food and Drug Administration (FDA), British Medicines and Healthcare Products Administration (MHRA), British National Health Service (NHS) and British Department of Health and Social Care (DHSC), Japanese Medicines And the Medical Device Administration (PMDA), Health Canada, Singapore's Health Sciences Agency (HSA), the American Association of Clinical Research Organizations (ACRO) and multiple ethical review committees have issued updated emergency response measures for clinical trials guidance during the COVID-19. In China alone, the number of newly enrolled patients participating in clinical trials in March decreased by 68% compared with the same period last year, so the demand for production and logistics services will also decline. But the good news is that after March, the number of newly enrolled patients began to rise sharply, and the number of new patients increased by 240% in March compared with February. This is a positive sign that clinical trials are gradually picking up.
Rising demand for outsourcing of drug discovery services
The global clinical trial market is thriving on account of the rising impetus given to research and development across several industries. Drug discovery forms an important niche of the pharmaceutical industry, and the extensive efforts employed by researchers to invent new drug models have popularized the market. Pharmaceutical companies have become increasingly concerned about manufacturing novel drugs and freeing the process of drug discovery from any hassles. Hence, outsourcing of drug discovery has emerged as a prominent trend amongst these companies, which has propelled demand within the market. Such as the prevalence of chronic diseases such as various cancer types and the increasing popularity of drug discovery service outsourcing will effectively promote the manufacturing demand in clinical trial supply services.
Strict and changing regulatory environment
Since clinical trial supply services are closely related to life and health, many regions have strict supervision systems for the production and packaging of clinical trials. The FDA and other regulatory agencies have increased stringency on the quality, storage, packaging and labeling, distribution, and recall of auxiliary products. The company now purchases auxiliary products at different levels, such as central procurement and regional procurement.
In addition, over a period of time, the regulatory environment in many countries/regions is very dynamic and changes rapidly. The constant changes in regulations and regional regulatory agencies will affect the import of clinical trial supplies. Using import brokers to overcome regional difficulties, such as complying with import and export regulations for the transportation of clinical trial supplies, will affect pharmaceutical companies in the smooth progress of clinical trials.
Region Overview:
Geographically, North America held the largest market share – 42.78% in 2021.
Company Overview:
Thermo Fisher Scientific is one of the major players operating in the Clinical Trial Supply Services market, holding a share of 16.27% in 2021.
Thermo Fisher Scientific
Thermo Fisher Scientific, Inc. manufactures scientific instruments, consumables, and chemicals. The Company offers analytical instruments, laboratory equipment, software, services, consumables, reagents, chemicals, and supplies to pharmaceutical and biotech companies, hospitals and clinical diagnostic labs, universities, research institutions, and government agencies.
Catalent Pharma Solutions
Catalent, Inc. provides delivery technologies and development solutions for drugs, biologics, and consumer health products. The Company's oral, injectable, and respiratory delivery technologies address the diversity of the pharmaceutical industry including small molecules, large molecule biologics, and consumer health products.
Segmentation Overview:
By type, Logistics and Distribution segment accounted for the largest share of market in 2021.
Application Overview:
The market's largest segment by application is the segment Oncology, with a market share of 20.97% in 2021.
The Clinical Trial Supply Services market report covers sufficient and comprehensive data on market introduction, segmentations, status and trends, opportunities and challenges, industry chain, competitive analysis, company profiles, and trade statistics, etc. It provides in-depth and all-scale analysis of each segment of types, applications, players, 5 major regions and sub-division of major countries, and sometimes end user, channel, technology, as well as other information individually tailored before order confirmation.
Meticulous research and analysis were conducted during the preparation process of the report. The qualitative and quantitative data were gained and verified through primary and secondary sources, which include but not limited to Magazines, Press Releases, Paid Databases, Maia Data Center, National Customs, Annual Reports, Public Databases, Expert interviews, etc. Besides, primary sources include extensive interviews of key opinion leaders and industry experts such as experienced front-line staff, directors, CEOs, and marketing executives, downstream distributors, as well as end-clients.
In this report, the historical period starts from 2018 to 2022, and the forecast period ranges from 2023 to 2028. The facts and data are demonstrated by tables, graphs, pie charts, and other pictorial representations, which enhances the effective visual representation and decision-making capabilities for business strategy.
Key Companies in the global Clinical Trial Supply Services market covered in Chapter 4:
Piramal Pharma Solutions
Movianto
MARKEN (UPS)
Parexel International
Almac Group
Catalent Pharma Solutions
Bilcare Limited
Biocair
PCI Services
Sharp (UDG Healthcare)
Thermo Fisher Scientific
Clinigen
World Courier
In Chapter 12 and Chapter 14.1, on the basis of types, the Clinical Trial Supply Services market from 2018 to 2028 is primarily split into:
Logistics and Distribution
Packaging and Labeling
Manufacturing
Others
In Chapter 13 and Chapter 14.2, on the basis of the Downstream Industry, the Clinical Trial Supply Services market from 2018 to 2028 covers:
Oncology
Cardiovascular Diseases
Respiratory Diseases
CNS and Mental Disorders
Dermatology
Blood Disorders
Infectious Diseases
Others
Geographically, the detailed analysis of consumption, revenue, market share and growth rate, history and forecast (2018-2028) of the following regions are covered in Chapters 6, 7, 8, 9, 10, 11, 15:
North America (United States, Canada, Mexico)
Europe (Germany, United Kingdom, France, Italy, Spain)
Asia Pacific (China, Japan, South Korea, India, Southeast Asia)
South America (Brazil, Argentina)
Middle East & Africa (Saudi Arabia, UAE, South Africa)
Outline:
Chapter 1 begins with the Clinical Trial Supply Services market scope and definition, product segment introduction, global overall market size, as well as market dynamics scenarios such as opportunities, challenges, and industry development trends under inflation. It offers a high-level view of the current state of the Clinical Trial Supply Services market and its likely evolution in the short to mid-term and long term.
Chapter 2 provides Clinical Trial Supply Services industry chain analysis, covering raw materials analysis, cost structure, price estimate, and forecast, along with price-impacting factors, downstream channels, and major customers. It aims to help readers to grab insights into product upstream, midstream, and downstream fields.
Chapter 3 depicts Clinical Trial Supply Services industry competitive analysis regarding market concentration rate, saturation rate, feasibility analysis from new entrants, as well as substitute's status and trends. It indicates the developing space and prospects of the current industry.
Chapter 4 analyzes extensive company profiles, comprising company basic info, product or service profiles, and sales, price, value, gross, and gross margin 2018-2023. It incorporates the Clinical Trial Supply Services market ranking, benchmarks, and company business portfolio.
Chapter 5 presents trade statistics of import and export volume from 2018-2023, demonstrating domestic and international market comparisons in specific countries.
Chapters 6-10 highlight Clinical Trial Supply Services market status at the regional and country levels, including 5 major regions of North America, Europe, Asia Pacific, the Middle East and Africa, and Latin America. The region and country list in the sample is only for reference, and it can be adjusted as required.
Chapter 11 involves geographical market figures of sales, value, market share, and growth rate. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of each specific region.
Chapters 12-13 evaluate the Clinical Trial Supply Services market based on different types and applications. It focuses on sales and value of 2018-2023 from both vertical and horizontal perspectives.
Chapters 14-15 elaborate on the Clinical Trial Supply Services market forecast data from 2023-2028, segmented by types and applications, regions, and major countries, helping readers to know future aspects and growth trends.
Chapter 16 ends with an elaboration of data sources and research methodology. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.
2022
Clinical Trial Supply Services refers to the manufacturing, packaging, storage, distribution, project management, and inventory management for in clinical trial activities. Clinical Trial Supply Services include, but are not limited to, project management, clinical packaging, labeling, supply chain logistics, distribution, return drug accountability, and destruction.
The number of new groups in clinical trials dropped sharply at the beginning of the year because of COVID-19
Globally, COVID-19 is still raging. Many pharmaceutical companies suspend clinical trials due to the epidemic. Because of the recruitment of patients in most regions of the world was severely affected. In March, the number of enrolled groups in global clinical trials dropped by 65.1% year-on-year compared with 2019
European Medicines Agency (EMA), U.S. Food and Drug Administration (FDA), British Medicines and Healthcare Products Administration (MHRA), British National Health Service (NHS) and British Department of Health and Social Care (DHSC), Japanese Medicines And the Medical Device Administration (PMDA), Health Canada, Singapore's Health Sciences Agency (HSA), the American Association of Clinical Research Organizations (ACRO) and multiple ethical review committees have issued updated emergency response measures for clinical trials guidance during the COVID-19. In China alone, the number of newly enrolled patients participating in clinical trials in March decreased by 68% compared with the same period last year, so the demand for production and logistics services will also decline. But the good news is that after March, the number of newly enrolled patients began to rise sharply, and the number of new patients increased by 240% in March compared with February. This is a positive sign that clinical trials are gradually picking up.
Rising demand for outsourcing of drug discovery services
The global clinical trial market is thriving on account of the rising impetus given to research and development across several industries. Drug discovery forms an important niche of the pharmaceutical industry, and the extensive efforts employed by researchers to invent new drug models have popularized the market. Pharmaceutical companies have become increasingly concerned about manufacturing novel drugs and freeing the process of drug discovery from any hassles. Hence, outsourcing of drug discovery has emerged as a prominent trend amongst these companies, which has propelled demand within the market. Such as the prevalence of chronic diseases such as various cancer types and the increasing popularity of drug discovery service outsourcing will effectively promote the manufacturing demand in clinical trial supply services.
Strict and changing regulatory environment
Since clinical trial supply services are closely related to life and health, many regions have strict supervision systems for the production and packaging of clinical trials. The FDA and other regulatory agencies have increased stringency on the quality, storage, packaging and labeling, distribution, and recall of auxiliary products. The company now purchases auxiliary products at different levels, such as central procurement and regional procurement.
In addition, over a period of time, the regulatory environment in many countries/regions is very dynamic and changes rapidly. The constant changes in regulations and regional regulatory agencies will affect the import of clinical trial supplies. Using import brokers to overcome regional difficulties, such as complying with import and export regulations for the transportation of clinical trial supplies, will affect pharmaceutical companies in the smooth progress of clinical trials.
Region Overview:
Geographically, North America held the largest market share – 42.78% in 2021.
Company Overview:
Thermo Fisher Scientific is one of the major players operating in the Clinical Trial Supply Services market, holding a share of 16.27% in 2021.
Thermo Fisher Scientific
Thermo Fisher Scientific, Inc. manufactures scientific instruments, consumables, and chemicals. The Company offers analytical instruments, laboratory equipment, software, services, consumables, reagents, chemicals, and supplies to pharmaceutical and biotech companies, hospitals and clinical diagnostic labs, universities, research institutions, and government agencies.
Catalent Pharma Solutions
Catalent, Inc. provides delivery technologies and development solutions for drugs, biologics, and consumer health products. The Company's oral, injectable, and respiratory delivery technologies address the diversity of the pharmaceutical industry including small molecules, large molecule biologics, and consumer health products.
Segmentation Overview:
By type, Logistics and Distribution segment accounted for the largest share of market in 2021.
Application Overview:
The market's largest segment by application is the segment Oncology, with a market share of 20.97% in 2021.
The Clinical Trial Supply Services market report covers sufficient and comprehensive data on market introduction, segmentations, status and trends, opportunities and challenges, industry chain, competitive analysis, company profiles, and trade statistics, etc. It provides in-depth and all-scale analysis of each segment of types, applications, players, 5 major regions and sub-division of major countries, and sometimes end user, channel, technology, as well as other information individually tailored before order confirmation.
Meticulous research and analysis were conducted during the preparation process of the report. The qualitative and quantitative data were gained and verified through primary and secondary sources, which include but not limited to Magazines, Press Releases, Paid Databases, Maia Data Center, National Customs, Annual Reports, Public Databases, Expert interviews, etc. Besides, primary sources include extensive interviews of key opinion leaders and industry experts such as experienced front-line staff, directors, CEOs, and marketing executives, downstream distributors, as well as end-clients.
In this report, the historical period starts from 2018 to 2022, and the forecast period ranges from 2023 to 2028. The facts and data are demonstrated by tables, graphs, pie charts, and other pictorial representations, which enhances the effective visual representation and decision-making capabilities for business strategy.
Key Companies in the global Clinical Trial Supply Services market covered in Chapter 4:
Piramal Pharma Solutions
Movianto
MARKEN (UPS)
Parexel International
Almac Group
Catalent Pharma Solutions
Bilcare Limited
Biocair
PCI Services
Sharp (UDG Healthcare)
Thermo Fisher Scientific
Clinigen
World Courier
In Chapter 12 and Chapter 14.1, on the basis of types, the Clinical Trial Supply Services market from 2018 to 2028 is primarily split into:
Logistics and Distribution
Packaging and Labeling
Manufacturing
Others
In Chapter 13 and Chapter 14.2, on the basis of the Downstream Industry, the Clinical Trial Supply Services market from 2018 to 2028 covers:
Oncology
Cardiovascular Diseases
Respiratory Diseases
CNS and Mental Disorders
Dermatology
Blood Disorders
Infectious Diseases
Others
Geographically, the detailed analysis of consumption, revenue, market share and growth rate, history and forecast (2018-2028) of the following regions are covered in Chapters 6, 7, 8, 9, 10, 11, 15:
North America (United States, Canada, Mexico)
Europe (Germany, United Kingdom, France, Italy, Spain)
Asia Pacific (China, Japan, South Korea, India, Southeast Asia)
South America (Brazil, Argentina)
Middle East & Africa (Saudi Arabia, UAE, South Africa)
Outline:
Chapter 1 begins with the Clinical Trial Supply Services market scope and definition, product segment introduction, global overall market size, as well as market dynamics scenarios such as opportunities, challenges, and industry development trends under inflation. It offers a high-level view of the current state of the Clinical Trial Supply Services market and its likely evolution in the short to mid-term and long term.
Chapter 2 provides Clinical Trial Supply Services industry chain analysis, covering raw materials analysis, cost structure, price estimate, and forecast, along with price-impacting factors, downstream channels, and major customers. It aims to help readers to grab insights into product upstream, midstream, and downstream fields.
Chapter 3 depicts Clinical Trial Supply Services industry competitive analysis regarding market concentration rate, saturation rate, feasibility analysis from new entrants, as well as substitute's status and trends. It indicates the developing space and prospects of the current industry.
Chapter 4 analyzes extensive company profiles, comprising company basic info, product or service profiles, and sales, price, value, gross, and gross margin 2018-2023. It incorporates the Clinical Trial Supply Services market ranking, benchmarks, and company business portfolio.
Chapter 5 presents trade statistics of import and export volume from 2018-2023, demonstrating domestic and international market comparisons in specific countries.
Chapters 6-10 highlight Clinical Trial Supply Services market status at the regional and country levels, including 5 major regions of North America, Europe, Asia Pacific, the Middle East and Africa, and Latin America. The region and country list in the sample is only for reference, and it can be adjusted as required.
Chapter 11 involves geographical market figures of sales, value, market share, and growth rate. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of each specific region.
Chapters 12-13 evaluate the Clinical Trial Supply Services market based on different types and applications. It focuses on sales and value of 2018-2023 from both vertical and horizontal perspectives.
Chapters 14-15 elaborate on the Clinical Trial Supply Services market forecast data from 2023-2028, segmented by types and applications, regions, and major countries, helping readers to know future aspects and growth trends.
Chapter 16 ends with an elaboration of data sources and research methodology. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.
Years considered for this report:
Historical Years:
2018-2022Base Year:
2022Estimated Year:
2023Forecast Period:
2023-2028Frequently Asked Questions
This market study covers the global and regional market with an in-depth analysis of the overall growth prospects in the market. Furthermore, it sheds light on the comprehensive competitive landscape of the global market. The report further offers a dashboard overview of leading companies encompassing their successful marketing strategies, market contribution, recent developments in both historic and present contexts.
- By product type
- By End User/Applications
- By Technology
- By Region
The report provides a detailed evaluation of the market by highlighting information on different aspects which include drivers, restraints, opportunities, and threats. This information can help stakeholders to make appropriate decisions before investing.
